MOLN - Molecular Partners - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

37.96M

Cash

174.1M

Avg Qtr Burn

-14.88M

Short % of Float

0.50%

Insider Ownership

0.00%

Institutional Own.

2.88%

Qtr Updated

03/31/24

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
MP0533 (CD33-CD123-CD70) Details Relapsed/refractory acute myeloid leukemia, High risk myelodysplastic syndromes , Acute myeloid leukemia	Phase 1/2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
MP0317 (FAP X CD40) Details Solid tumor/s	Phase 1 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Ensovibep Details COVID-19	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.